Key Takeaways
- • Rightway, a pharmacy benefit management and care navigation platform, raised $155 million in Series E funding led by Francisco Partners, with participation from existing investors Thrive Capital and Khosla Ventures.
- • The financing reflects growing institutional demand for pharmacy cost transparency and member support solutions as employers face mounting pressure to control pharmacy spending and demonstrate accountability.
- • Francisco Partners' lead investment signals confidence in Rightway's technology-driven approach to PBM services, a sector increasingly focused on digital transformation and care coordination.
- • The capital infusion will fund Rightway's expansion efforts as the company positions itself to capture market share from traditional PBM models facing criticism over cost management and transparency.
Summary
Rightway announced the closing of a $155 million Series E funding round on September 25, 2026, led by Francisco Partners, a global investment firm specializing in technology company partnerships. The round included continued participation from existing backers Thrive Capital and Khosla Ventures, underscoring sustained confidence in the company's business model and market positioning.
Rightway operates in the pharmacy benefit management and care navigation space, serving employers seeking greater oversight of pharmacy expenditures and enhanced member support. The company's positioning directly addresses a critical pain point for enterprise clients: the need for transparency and accountability in pharmacy spending, an area where traditional PBM models have faced increased scrutiny from employers and regulators.
The Series E capital will support Rightway's next phase of growth as the company capitalizes on structural demand shifts within the healthcare and benefits administration markets. Employers increasingly demand alternatives to legacy PBM arrangements, creating an expanded addressable market for technology-enabled competitors focused on cost control, member experience, and operational transparency. Francisco Partners' involvement reflects the broader investment thesis that specialized healthcare technology companies solving specific enterprise pain points represent attractive growth opportunities in the current market environment.
Rightway operates in the pharmacy benefit management and care navigation space, serving employers seeking greater oversight of pharmacy expenditures and enhanced member support. The company's positioning directly addresses a critical pain point for enterprise clients: the need for transparency and accountability in pharmacy spending, an area where traditional PBM models have faced increased scrutiny from employers and regulators.
The Series E capital will support Rightway's next phase of growth as the company capitalizes on structural demand shifts within the healthcare and benefits administration markets. Employers increasingly demand alternatives to legacy PBM arrangements, creating an expanded addressable market for technology-enabled competitors focused on cost control, member experience, and operational transparency. Francisco Partners' involvement reflects the broader investment thesis that specialized healthcare technology companies solving specific enterprise pain points represent attractive growth opportunities in the current market environment.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.